RFK Jr.'s HHS Appointment Sparks Health Sector Concerns
Health stocks fell sharply after Donald Trump nominated vaccine skeptic Robert F. Kennedy Jr. as US Health Secretary, raising concerns about potential regulatory changes. Shares in major pharmaceutical companies like Pfizer, Moderna, AstraZeneca, and GSK dropped significantly, reflecting investor uncertainty. Kennedy's stance against "Big Pharma" and his history of spreading controversial health information have spooked the market, despite unclear policy directions. The nomination, if confirmed, could signal a shift from previous administrations' approaches to healthcare regulation.